Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
…, J Tubprasert, MY Abdad, S Keayarsa… - BMC Infectious …, 2024 - Springer
Brief summary In early symptomatic COVID-19 treatment, high dose oral favipiravir did not
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …
accelerate viral clearance. Background Favipiravir, an anti-influenza drug, has in vitro antiviral …
Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV)
…, J Tubprasert, MY Abdad, S Keayarsa… - The Journal of …, 2023 - academic.oup.com
Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …
disease 2019 (COVID-19) has resulted in varying treatment guidelines. Methods In a …
Effects of sevuparin on rosette formation and cytoadherence of Plasmodium falciparum infected erythrocytes
S Saiwaew, J Sritabal, N Piaraksa, S Keayarsa… - PLoS …, 2017 - journals.plos.org
In severe falciparum malaria cytoadherence of parasitised red blood cells (PRBCs) to
vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette …
vascular endothelium (causing sequestration) and to uninfected red cells (causing rosette …
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a …
…, J Tubprasert, M Abdad, S Keayarsa… - The Lancet Infectious …, 2024 - thelancet.com
Background Effective antiviral drugs prevent hospitalisation and death from COVID-19.
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …
Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 …
Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants
…, T Ngernseng, J Tubprasert, MY Abdad, S Keayarsa… - medRxiv, 2022 - medrxiv.org
Background Uncertainty over the therapeutic benefit provided by parenteral remdesivir in
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …
[HTML][HTML] Temperature dependence of Plasmodium falciparum erythrocytic stage development
Y Singhaboot, S Keayarsa, N Piaraksa… - The American journal …, 2019 - ncbi.nlm.nih.gov
Plasmodium falciparum infection causes febrile illness and severe disease with multiple
organ failure and death when treatment is delayed. Antipyretic treatment is standard, and …
organ failure and death when treatment is delayed. Antipyretic treatment is standard, and …
Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants (preprint)
…, T Ngernseng, J Tubprasert, MY Abdad, S Keayarsa… - 2022 - pesquisa.bvsalud.org
BackgroundUncertainty over the therapeutic benefit provided by parenteral remdesivir in
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …
COVID-19 has resulted in varying treatment guidelines. Early in the pandemic the monoclonal …
Gametocyte and malaria transmission.
N Piaraksa, Y Singhaboot, S Keayarsa… - 2017 - cabidigitallibrary.org
Prevention of malaria transmission from human to mosquitoes is one of the crucial factors
required for malaria elimination. Gametocytes representing the sexual erythrocytic stage of …
required for malaria elimination. Gametocytes representing the sexual erythrocytic stage of …
[CITATION][C] การ ศึกษา คุณลักษณะ ของ เอนไซม์ ฟ รุก โต ซิ ล ท ราน ส เฟ อ เร ส จาก แก่น ตะวัน เพื่อ นำ ไป ผลิต ฟ รุก โต ลิ โก แซ ค คา ไร ด์
ศรี สุดา เคย อาษา - 2011 - มหาวิทยาลัย ศิลปากร
